The Pennsylvania Breast Cancer Coalition Hails Decline in Breast Cancer Rates; Startling Findings Should Encourage Researchers to Focus on Why
Posted on: Friday, 15 December 2006, 18:00 CST
EPHRATA, Pa., Dec. 15 /PRNewswire/ -- The Pennsylvania Breast Cancer Coalition is hailing the news that United States breast cancer rates dropped drastically in 2003, as first reported by the Associated Press in a 12/14/2006 article. The report indicates a 7.2 percent decline in breast cancer diagnosis in 2003. The decline is attributed to the fact that fewer women are taking hormone pills following the federal study that revealed that menopause hormones often put women at higher risk for breast cancer, heart disease, and other health issues. The study caused millions of women to stop taking the pills.
"It is startlingly good news to know that breast cancer rates decreased so dramatically in 2003," said PBCC President & Founder Pat Halpin-Murphy. "Our goal now must be to build upon these findings and uncover exactly why such a decrease occurred, and how we can use these findings in our search toward a cure for breast cancer."
Recent trends suggested that approximately 200,000 cases of breast cancer would be diagnosed in 2003. The seven percent drop indicates that about 14,000 fewer cases were diagnosed.
The Pennsylvania Breast Cancer Coalition, founded in 1993, is a non-profit organization and the only statewide grassroots organization that speaks to and for breast cancer survivors. This year, more than 12,000 Pennsylvania women will be diagnosed with breast cancer. More than 2,300 will lose their lives to the disease. The PBCC's mission is to help find a cure for breast cancer and to improve the quality of breast cancer education, research and outreach in the state.
Pennsylvania Breast Cancer Coalition
CONTACT: Amy Collins, The Pennsylvania Breast Cancer Coalition,+1-717-738-9567 x106, or +1-412-805-9929
Web site: http://www.pabreastcancer.org/
Source: PRNewswire
Related Articles
- The Pennsylvania Breast Cancer Coalition Offers Seminar on Free Treatment for Breast Cancer
- Susan G. Komen For The Cure(R) to Invest $60 Million in Research to Accelerate Breast Cancer Cures, Eliminate Disparities, Improve Diagnoses
- Fewer Swedish Women Getting Breast Cancer
- Less Swedish Women Getting Breast Cancer
- FDA Approves TYKERB(R) (Lapatinib) in Combination With Xeloda(R) (Capecitabine) for the Treatment of Advanced or Metastatic Breast Cancer in Women Who Have Progressed on Prior Therapy
- X-rays raise breast cancer risk in some women: study
- X-rays Raise Breast Cancer Risk in Some Women
- Does Energy Balancing Therapy Provide Relief for Breast Cancer Patients?; Women's Health @ Stanford Offers Free Therapy and Studies Its Effects
- Weight Linked to Breast Cancer in Women With Gene Mutation
- Life After Breast Cancer ; BATTLING WOMEN WHO BOUNCED BACK FROM THE BRINK OF DEATH
 |
 |
User Comments (0)
RSS Feeds